Relative survival of patients with supratentorial low-grade gliomas

We sought to assess the population-based estimates of age-standardized survival among patients with low-grade gliomas (LGG) and to determine the impact of age and time on relative survival (RS). Data from the Surveillance, Epidemiology, and End Results (SEER) program of NCI from 1973 through 2006 we...

Full description

Saved in:
Bibliographic Details
Published inNeuro-oncology (Charlottesville, Va.) Vol. 14; no. 8; pp. 1062 - 1069
Main Authors Smoll, Nicolas R, Gautschi, Oliver P, Schatlo, Bawarjan, Schaller, Karl, Weber, Damien C
Format Journal Article
LanguageEnglish
Published England Oxford University Press 01.08.2012
Subjects
Online AccessGet full text

Cover

Loading…
Abstract We sought to assess the population-based estimates of age-standardized survival among patients with low-grade gliomas (LGG) and to determine the impact of age and time on relative survival (RS). Data from the Surveillance, Epidemiology, and End Results (SEER) program of NCI from 1973 through 2006 were analyzed to assess survival among 5037 patients. Relationships were modeled using Dickman's piecewise constant hazards RS model. The 3- and 10-year age-standardized RS were 67% and 37%, respectively. When analyzed by age group, the 10-year overall survival (OS) and RS for children (age, <16 years), young adults (age, 16-39 years), adults (age, 40-64 years), and older patients (age, ≥65 years) were 86% and 86%, 61% and 62%, 40% and 43%, and 10% and 14%, respectively. The observed difference between OS and RS was larger among older patients (4%) and smallest among children (<1%). Older patients were 30.5 times (excess hazard ratio [eHR]; 95% confidence interval [CI], 20.3-50.0) as likely as young adults to die during the first year and 18.2 times as likely to die during the second year. Adults were 5.3 (eHR; 95% CI, 3.5-8.1) times as likely to die during their first year as young adults. In the remaining years, the observed survival differences were substantially decreased, and the presence of an age-by-follow-up interaction was observed. Survival among older patients with LGG was substantially different from the one computed for young adults and children. Despite the hazards across age groups not being proportional, RS does not provide additional information, compared with OS, in patients with LGG.
AbstractList We sought to assess the population-based estimates of age-standardized survival among patients with low-grade gliomas (LGG) and to determine the impact of age and time on relative survival (RS). Data from the Surveillance, Epidemiology, and End Results (SEER) program of NCI from 1973 through 2006 were analyzed to assess survival among 5037 patients. Relationships were modeled using Dickman's piecewise constant hazards RS model. The 3- and 10-year age-standardized RS were 67% and 37%, respectively. When analyzed by age group, the 10-year overall survival (OS) and RS for children (age, <16 years), young adults (age, 16-39 years), adults (age, 40-64 years), and older patients (age, greater than or equal to 65 years) were 86% and 86%, 61% and 62%, 40% and 43%, and 10% and 14%, respectively. The observed difference between OS and RS was larger among older patients (4%) and smallest among children (<1%). Older patients were 30.5 times (excess hazard ratio [eHR]; 95% confidence interval [CI], 20.3-50.0) as likely as young adults to die during the first year and 18.2 times as likely to die during the second year. Adults were 5.3 (eHR; 95% CI, 3.5-8.1) times as likely to die during their first year as young adults. In the remaining years, the observed survival differences were substantially decreased, and the presence of an age-by-follow-up interaction was observed. Survival among older patients with LGG was substantially different from the one computed for young adults and children. Despite the hazards across age groups not being proportional, RS does not provide additional information, compared with OS, in patients with LGG.
We sought to assess the population-based estimates of age-standardized survival among patients with low-grade gliomas (LGG) and to determine the impact of age and time on relative survival (RS). Data from the Surveillance, Epidemiology, and End Results (SEER) program of NCI from 1973 through 2006 were analyzed to assess survival among 5037 patients. Relationships were modeled using Dickman's piecewise constant hazards RS model. The 3- and 10-year age-standardized RS were 67% and 37%, respectively. When analyzed by age group, the 10-year overall survival (OS) and RS for children (age, <16 years), young adults (age, 16-39 years), adults (age, 40-64 years), and older patients (age, ≥65 years) were 86% and 86%, 61% and 62%, 40% and 43%, and 10% and 14%, respectively. The observed difference between OS and RS was larger among older patients (4%) and smallest among children (<1%). Older patients were 30.5 times (excess hazard ratio [eHR]; 95% confidence interval [CI], 20.3-50.0) as likely as young adults to die during the first year and 18.2 times as likely to die during the second year. Adults were 5.3 (eHR; 95% CI, 3.5-8.1) times as likely to die during their first year as young adults. In the remaining years, the observed survival differences were substantially decreased, and the presence of an age-by-follow-up interaction was observed. Survival among older patients with LGG was substantially different from the one computed for young adults and children. Despite the hazards across age groups not being proportional, RS does not provide additional information, compared with OS, in patients with LGG.
Author Gautschi, Oliver P
Schaller, Karl
Weber, Damien C
Schatlo, Bawarjan
Smoll, Nicolas R
AuthorAffiliation Department of Clinical Neurosciences, Department of Neurosurgery, Geneva University Hospital, Geneva , Switzerland (N.R.S., O.P.G., B.S., K.S.); Gippsland Medical School , Monash University , Churchill, Victoria , Australia (N.R.S.); Department of Radiation Oncology , Geneva University Hospital , Geneva , Switzerland (D.C.W.)
AuthorAffiliation_xml – name: Department of Clinical Neurosciences, Department of Neurosurgery, Geneva University Hospital, Geneva , Switzerland (N.R.S., O.P.G., B.S., K.S.); Gippsland Medical School , Monash University , Churchill, Victoria , Australia (N.R.S.); Department of Radiation Oncology , Geneva University Hospital , Geneva , Switzerland (D.C.W.)
Author_xml – sequence: 1
  givenname: Nicolas R
  surname: Smoll
  fullname: Smoll, Nicolas R
  email: nrsmoll@me.com
  organization: Department of Clinical Neurosciences, Department of Neurosurgery, Geneva University Hospital, Geneva, Switzerland. nrsmoll@me.com
– sequence: 2
  givenname: Oliver P
  surname: Gautschi
  fullname: Gautschi, Oliver P
– sequence: 3
  givenname: Bawarjan
  surname: Schatlo
  fullname: Schatlo, Bawarjan
– sequence: 4
  givenname: Karl
  surname: Schaller
  fullname: Schaller, Karl
– sequence: 5
  givenname: Damien C
  surname: Weber
  fullname: Weber, Damien C
BackLink https://www.ncbi.nlm.nih.gov/pubmed/22773277$$D View this record in MEDLINE/PubMed
BookMark eNqFkUtLAzEUhYNU7EOXbmWWbsbmOZnZCFJ8QUEQXYdM5k4bmU5qMtPivzfaWnTlIiQ35-NwLmeMBq1rAaFzgq8ILti0hd61Ztq6QDg_QiMiKEtFnmWD7zdNc0HkEI1DeMOYEpGREzSkVEoWzwjNnqHRnd1AEnq_sRvdJK5O1vEL2i4kW9sto7L2uouz8zbqjdumC68rSBaNdSsdTtFxrZsAZ_t7gl7vbl9mD-n86f5xdjNPDae4S03NDSm01sA4lYUoZIUJFCSXHFMhGRDgpTClpiUuCp5pzKEujJY0pxLnFZug653vui9XUJmYyOtGrb1daf-hnLbqr9LapVq4jWIc5zTLosHl3sC79x5Cp1Y2GGga3YLrgyJCkIxnlNL_UcxwLiljJKLpDjXeheChPiQiWH11pHYdqV1Hkb_4vcaB_imFfQJX8ZIr
CitedBy_id crossref_primary_10_3389_fgene_2022_1036460
crossref_primary_10_3389_fimmu_2021_731048
crossref_primary_10_2147_OTT_S258631
crossref_primary_10_1002_cncr_28032
crossref_primary_10_1055_s_0042_1742333
crossref_primary_10_3389_fneur_2020_610163
crossref_primary_10_1016_j_compbiomed_2016_12_017
crossref_primary_10_2217_cns_14_7
crossref_primary_10_3389_fcell_2020_594112
crossref_primary_10_1155_2020_7035847
crossref_primary_10_3390_radiation1030019
crossref_primary_10_3892_ol_2015_3183
crossref_primary_10_1080_14737175_2018_1425617
crossref_primary_10_1007_s11060_015_1952_5
crossref_primary_10_1093_neuonc_nou053
crossref_primary_10_3390_nu12010196
crossref_primary_10_1111_ane_12973
crossref_primary_10_1155_2022_1734847
crossref_primary_10_1016_j_clon_2013_04_005
crossref_primary_10_1093_neuonc_noy095
crossref_primary_10_3892_etm_2015_2906
crossref_primary_10_1016_j_isci_2022_104918
crossref_primary_10_3892_etm_2023_11952
crossref_primary_10_7314_APJCP_2014_15_16_6973
crossref_primary_10_1038_s41392_021_00855_2
crossref_primary_10_1007_s11060_013_1103_9
crossref_primary_10_1186_s12883_022_02879_9
crossref_primary_10_1002_cncr_29237
crossref_primary_10_3389_fmolb_2021_706949
crossref_primary_10_1515_revneuro_2016_0066
crossref_primary_10_3390_genes14030701
crossref_primary_10_1007_s11060_014_1563_6
crossref_primary_10_3389_fgene_2022_1026192
crossref_primary_10_3892_mmr_2015_4129
crossref_primary_10_1016_j_radonc_2019_04_027
crossref_primary_10_1042_BSR20170100
crossref_primary_10_3389_fcell_2023_1295891
crossref_primary_10_1002_adbi_202300439
crossref_primary_10_1016_j_suronc_2016_09_003
Cites_doi 10.1200/JCO.2002.08.121
10.1200/JCO.2009.25.7121
10.1215/15228517-2006-036
10.1038/sj.bjc.6603390
10.1002/mpo.2950250603
10.1002/1097-0142(19851001)56:7+<1818::AID-CNCR2820561320>3.0.CO;2-9
10.1056/NEJM199403313301303
10.1002/sim.1597
10.1016/S0360-3016(96)00352-5
10.1002/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO;2-#
10.1002/jso.20036
10.1017/S0317167100008313
10.1016/j.ejca.2011.03.011
10.1002/cncr.26387
10.1007/s00401-005-0991-y
10.1016/S0140-6736(05)67070-5
10.1002/cncr.21733
10.1200/JCO.2006.06.8213
10.1212/WNL.0b013e3181c6781e
10.1016/S0360-3016(01)02692-X
10.3171/jns.1996.84.5.0721
10.1212/01.wnl.0000218270.12495.9a
10.1200/JCO.2006.05.9238
ContentType Journal Article
Copyright The Author(s) 2012. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2012
Copyright_xml – notice: The Author(s) 2012. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. 2012
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
7TK
5PM
DOI 10.1093/neuonc/nos144
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
Neurosciences Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
Neurosciences Abstracts
DatabaseTitleList Neurosciences Abstracts
MEDLINE - Academic
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1523-5866
EndPage 1069
ExternalDocumentID 10_1093_neuonc_nos144
22773277
Genre Journal Article
GroupedDBID ---
.2P
.I3
.XZ
.ZR
0R~
123
18M
1TH
29N
2WC
36B
4.4
48X
53G
5VS
5WD
70D
AABZA
AACZT
AAJKP
AAJQQ
AAMDB
AAMVS
AAOGV
AAPNW
AAPQZ
AAPXW
AARHZ
AAUAY
AAUQX
AAVAP
ABEUO
ABIXL
ABJNI
ABKDP
ABNHQ
ABNKS
ABPTD
ABQLI
ABQNK
ABWST
ABXVV
ABZBJ
ACGFO
ACGFS
ACUFI
ACUTO
ACYHN
ADBBV
ADEYI
ADGZP
ADHKW
ADHZD
ADIPN
ADJQC
ADOCK
ADQBN
ADRIX
ADRTK
ADVEK
ADYVW
ADZXQ
AEGPL
AEGXH
AEJOX
AEKSI
AEMDU
AENEX
AENZO
AEPUE
AETBJ
AEWNT
AFFZL
AFIYH
AFOFC
AFXAL
AFXEN
AGINJ
AGKEF
AGQXC
AGSYK
AGUTN
AHXPO
AIAGR
AIJHB
AJEEA
AKWXX
ALMA_UNASSIGNED_HOLDINGS
ALUQC
AOIJS
APIBT
APWMN
ATGXG
AXUDD
BAWUL
BAYMD
BCRHZ
BEYMZ
BHONS
BTRTY
BVRKM
C45
CDBKE
CGR
CS3
CUY
CVF
CZ4
DAKXR
DIK
DILTD
DU5
D~K
E3Z
EBS
ECM
EE~
EIF
EJD
EMB
EMOBN
ENERS
F5P
F9B
FECEO
FLUFQ
FOEOM
FOTVD
FQBLK
GAUVT
GJXCC
GX1
H13
H5~
HAR
HW0
HYE
HZ~
IOX
J21
KBUDW
KOP
KQ8
KSI
KSN
M49
MHKGH
N9A
NGC
NOMLY
NOYVH
NPM
NU-
O0~
O9-
OAUYM
OAWHX
OCZFY
ODMLO
OJQWA
OJZSN
OK1
OPAEJ
OVD
OWPYF
P2P
P6G
PAFKI
PEELM
Q1.
Q5Y
RD5
RHF
ROX
RPM
RUSNO
RW1
RXO
SV3
TEORI
TJX
TR2
UDS
W8F
WOQ
X7H
YAYTL
YKOAZ
YXANX
~91
AASNB
AAYXX
CITATION
7X8
7TK
5PM
ID FETCH-LOGICAL-c420t-cf4c19aaae34279597d01e9187402573e1e4b5cba2b09946a04ef9ca7282708d3
IEDL.DBID RPM
ISSN 1522-8517
IngestDate Tue Sep 17 21:15:56 EDT 2024
Fri Oct 25 23:18:37 EDT 2024
Fri Oct 25 10:56:38 EDT 2024
Fri Aug 23 02:51:29 EDT 2024
Wed Oct 16 00:52:16 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c420t-cf4c19aaae34279597d01e9187402573e1e4b5cba2b09946a04ef9ca7282708d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
OpenAccessLink https://academic.oup.com/neuro-oncology/article-pdf/14/8/1062/4030719/nos144.pdf
PMID 22773277
PQID 1030872331
PQPubID 23479
PageCount 8
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3408266
proquest_miscellaneous_1551646222
proquest_miscellaneous_1030872331
crossref_primary_10_1093_neuonc_nos144
pubmed_primary_22773277
PublicationCentury 2000
PublicationDate 2012-08-01
PublicationDateYYYYMMDD 2012-08-01
PublicationDate_xml – month: 08
  year: 2012
  text: 2012-08-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle Neuro-oncology (Charlottesville, Va.)
PublicationTitleAlternate Neuro Oncol
PublicationYear 2012
Publisher Oxford University Press
Publisher_xml – name: Oxford University Press
References (23_36447516) 2007; 9
Sutton (26_16206015) 1996; 84
(10_33609952) 1996; 78
van den Bent (4_19462302) 2005; 366
(17_43006990) 2007; 25
Felix (18_16049054) 1995; 25
Torres (27_14683914) 1994; 330
(16_41205203) 2010; 331
(24_43006992) 2002; 20
Walker (20_22983433) 2006; 95
(29_43006993) 1985; 56
(3_43006989) 2006; 45
Hakulinen (13_39886506) 2011; 47
Varela (22_18109566) 2004; 86
Karim (7_16541385) 1996; 36
Ohgaki (2_18680128) 2005; 109
Walker (19_22163591) 2006; 66
(5_33736729) 2006; 106
Karim (6_16938800) 2002; 52
Dickman (12_17973185) 2004; 23
(14_35969828) 2009; 73
Vassilyadi (28_36135661) 2009; 36
(21_43006991) 2006; 24
(15_37303171) 2010; 28
Smoll (25_40564859) 2012; 118
References_xml – volume: 20
  start-page: 2076
  year: 2002
  ident: 24_43006992
  publication-title: JOURNAL OF CLINICAL ONCOLOGY OFFICIAL JOURNAL OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY
  doi: 10.1200/JCO.2002.08.121
– volume: 28
  start-page: 3054
  issn: 0732-183X
  issue: 18
  year: 2010
  ident: 15_37303171
  publication-title: Journal of Clinical Oncology
  doi: 10.1200/JCO.2009.25.7121
– volume: 331
  start-page: 435
  issn: 0036-8075
  year: 2010
  ident: 16_41205203
  publication-title: Science
– volume: 9
  start-page: 113
  issn: 1522-8517
  issue: 2
  year: 2007
  ident: 23_36447516
  publication-title: Neuro-Oncology
  doi: 10.1215/15228517-2006-036
– volume: 95
  start-page: 1424
  issn: 1532-1827
  issue: 10
  year: 2006
  ident: 20_22983433
  publication-title: British Journal of Cancer
  doi: 10.1038/sj.bjc.6603390
  contributor:
    fullname: Walker
– volume: 45
  start-page: 272
  issn: 0001-6381
  year: 2006
  ident: 3_43006989
  publication-title: Acta oncol  gica
– volume: 25
  start-page: 431
  issn: 0098-1532
  issue: 6
  year: 1995
  ident: 18_16049054
  publication-title: Medical and pediatric oncology
  doi: 10.1002/mpo.2950250603
  contributor:
    fullname: Felix
– volume: 56
  start-page: 1818
  issn: 1097-0142
  year: 1985
  ident: 29_43006993
  doi: 10.1002/1097-0142(19851001)56:7+<1818::AID-CNCR2820561320>3.0.CO;2-9
– volume: 330
  start-page: 892
  issn: 0028-4793
  issue: 13
  year: 1994
  ident: 27_14683914
  publication-title: New England Journal of Medicine
  doi: 10.1056/NEJM199403313301303
  contributor:
    fullname: Torres
– volume: 23
  start-page: 51
  issn: 0277-6715
  issue: 1
  year: 2004
  ident: 12_17973185
  publication-title: Statistics in medicine
  doi: 10.1002/sim.1597
  contributor:
    fullname: Dickman
– volume: 36
  start-page: 549
  issn: 0360-3016
  issue: 3
  year: 1996
  ident: 7_16541385
  publication-title: International journal of radiation oncology, biology, physics
  doi: 10.1016/S0360-3016(96)00352-5
  contributor:
    fullname: Karim
– volume: 78
  start-page: 2004
  issn: 1097-0142
  year: 1996
  ident: 10_33609952
  doi: 10.1002/(SICI)1097-0142(19961101)78:9<2004::AID-CNCR23>3.0.CO;2-#
– volume: 86
  start-page: 34
  issn: 0022-4790
  issue: 1
  year: 2004
  ident: 22_18109566
  publication-title: Journal of surgical oncology
  doi: 10.1002/jso.20036
  contributor:
    fullname: Varela
– volume: 36
  start-page: 707
  issn: 0317-1671
  issue: 6
  year: 2009
  ident: 28_36135661
  publication-title: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
  doi: 10.1017/S0317167100008313
  contributor:
    fullname: Vassilyadi
– volume: 47
  start-page: 2202
  issn: 0959-8049
  issue: 14
  year: 2011
  ident: 13_39886506
  publication-title: European journal of cancer (Oxford, England : 1990)
  doi: 10.1016/j.ejca.2011.03.011
  contributor:
    fullname: Hakulinen
– volume: 118
  start-page: 1313
  issn: 1097-0142
  issue: 5
  year: 2012
  ident: 25_40564859
  doi: 10.1002/cncr.26387
  contributor:
    fullname: Smoll
– volume: 109
  start-page: 93
  issn: 0001-6322
  issue: 1
  year: 2005
  ident: 2_18680128
  publication-title: Acta neuropathologica
  doi: 10.1007/s00401-005-0991-y
  contributor:
    fullname: Ohgaki
– volume: 366
  start-page: 985
  issn: 0140-6736
  issue: 9490
  year: 2005
  ident: 4_19462302
  publication-title: Lancet
  doi: 10.1016/S0140-6736(05)67070-5
  contributor:
    fullname: van den Bent
– volume: 106
  start-page: 1358
  issn: 1097-0142
  year: 2006
  ident: 5_33736729
  doi: 10.1002/cncr.21733
– volume: 25
  start-page: 682
  year: 2007
  ident: 17_43006990
  publication-title: JOURNAL OF CLINICAL ONCOLOGY OFFICIAL JOURNAL OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY
  doi: 10.1200/JCO.2006.06.8213
– volume: 73
  start-page: 2093
  issn: 0028-3878
  issue: 24
  year: 2009
  ident: 14_35969828
  publication-title: Neurology
  doi: 10.1212/WNL.0b013e3181c6781e
– volume: 52
  start-page: 316
  issn: 0360-3016
  issue: 2
  year: 2002
  ident: 6_16938800
  publication-title: International journal of radiation oncology, biology, physics
  doi: 10.1016/S0360-3016(01)02692-X
  contributor:
    fullname: Karim
– volume: 84
  start-page: 721
  issn: 0022-3085
  issue: 5
  year: 1996
  ident: 26_16206015
  publication-title: Journal of neurosurgery
  doi: 10.3171/jns.1996.84.5.0721
  contributor:
    fullname: Sutton
– volume: 66
  start-page: 1661
  issn: 0028-3878
  issue: 11
  year: 2006
  ident: 19_22163591
  publication-title: Neurology
  doi: 10.1212/01.wnl.0000218270.12495.9a
  contributor:
    fullname: Walker
– volume: 24
  start-page: 4758
  year: 2006
  ident: 21_43006991
  publication-title: JOURNAL OF CLINICAL ONCOLOGY OFFICIAL JOURNAL OF THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY
  doi: 10.1200/JCO.2006.05.9238
SSID ssj0021561
Score 2.2647285
Snippet We sought to assess the population-based estimates of age-standardized survival among patients with low-grade gliomas (LGG) and to determine the impact of age...
SourceID pubmedcentral
proquest
crossref
pubmed
SourceType Open Access Repository
Aggregation Database
Index Database
StartPage 1062
SubjectTerms Adolescent
Adult
Age Distribution
Aged
Child
Clinical Investigations
Female
Glioma - mortality
Glioma - pathology
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Neoplasm Grading
SEER Program
Supratentorial Neoplasms - mortality
Supratentorial Neoplasms - pathology
Young Adult
Title Relative survival of patients with supratentorial low-grade gliomas
URI https://www.ncbi.nlm.nih.gov/pubmed/22773277
https://search.proquest.com/docview/1030872331
https://search.proquest.com/docview/1551646222
https://pubmed.ncbi.nlm.nih.gov/PMC3408266
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwED61HRAL4k15VEFCbGkedp1mRBWlQipioFK3yHacUql1qj7g73OOk4qCxMCQyY4Sne_i-3KfvwO469BMkJRipBlyGGXSd2P8FLsKEVDKMqnSgjw-fGGDEX0ed8Y16FRnYQrSvhTTtp7N23r6XnArF3PpVTwx73XYI6ZLMmNeHerooBVEL1EWAhIrkoooyzSeL4U1Ebl7Wm1yLT2drxBGGBngMIoIXrt70q9E8ydf8tsG1D-EgzJzdB7sGx5BTelj2BuWtfET6Fle24dyVhuMf_QgJ8-cUjd15ZgfrjiyMNIQ2iiD4Pgs_3QnS54qZzKbGqLQKYz6j2-9gVu2SHAlDf21KzMqg5hzrggNTdvwKPUDFReN9jAYiQoUFR0peCgwFaSM-1RlseQRIq3I76bkDBo61-oCHJGSriQki5lIqZSKUzRlUe5F8E0Ea8J9ZaRkYZUwElvBJok1bGIN24TbyoQJ-qopQHCt8s0qCQr9wZCQ4I85pnJHGaYtTTi3Zt8-rlqvJkQ7C7KdYLSyd0fQhQrN7NJlLv995xXsY64UWu7fNTTWy426wXxkLVpQfxoHrcILvwDJ6ePf
link.rule.ids 230,315,730,783,787,888,27936,27937,53804,53806
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwED5BkYAF8aY8g4TYQh52HTKiClSgRQwgsUW245RKrVO1Dfx9znFSUZAYGDLZUaLznX1f7st3ABctmgmSUow0Qw6jTPpujFuxqxABpSyTKi3J470n1nmlD2-ttyVo1f_ClKR9KQZXeji60oP3kls5Hkmv5ol5z702MV2SGfOWYQXj1ac1SK9wFkISK5OKOMu0nq-kNRG7e1oVuZaezqcIJIwQcBhFBK_FU-lXqvmTMfntCLrbhI0qd3Ru7DtuwZLS27Daq6rjO9C2zLYP5UwL3AHQh5w8cyrl1KljPrniyNiIQ2ijDYLjw_zT7U94qpz-cGCoQrvwenf70u64VZMEV9LQn7kyozKIOeeK0NA0Do9SP1Bx2WoPw5GoQFHRkoKHApNByrhPVRZLHiHWivzrlOxBQ-daHYAjUnItCcliJlIqpeIUTVkWfBF-E8GacFkbKRlbLYzE1rBJYg2bWMM24bw2YYLeakoQXKu8mCZBqUAYEhL8McfU7ijDxKUJ-9bs88fV69WEaGFB5hOMWvbiCDpRqZpdOc3hv-88g7XOS6-bdO-fHo9gHTOn0DIBj6ExmxTqBLOTmTgtffELj37mRA
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3JTsMwEB2xSBUXxE5Zg4S4pVnsOuSIChVbEQcq9RZ5C1QqTkVb-H3GcYIoSBw45GRbicYz9rzM0xuA0zbNBVEUI82SwyiToZ_iUexrRECK5VKrkjzee2DXfXo7aA--tfoqSftSDFtm9Noyw5eSWzl-lUHNEwseex1iuyQzFoxVHizCMsZsyGqgXmEthCVOKhWxlm0_X8lrIn4PjJ4VRgammCCYsGLAcZIQfOZvpl_p5k_W5LdrqLsGq1X-6F2471yHBW02oNGrKuSb0HHstnftTWZ4CqAfeUXuVeqpE8_-dsWRsRWIMFYfBMdHxYf__MaV9p5HQ0sX2oJ-9-qpc-1XjRJ8SeNw6sucyijlnGtCY9s8PFFhpNOy3R6GJNGRpqItBY8FJoSU8ZDqPJU8QbyVhOeKbMOSKYzeBU8oci4JyVMmFJVSc4qmLIu-CMGJYE04q42UjZ0eRubq2CRzhs2cYZtwUpswQ4-1ZQhudDGbZFGpQhgTEv0xx9bvKMPkpQk7zuxfr6v3qwnJ3IZ8TbCK2fMj6EilcnblOHv_XnkMjcfLbnZ_83C3DyuYPMWODHgAS9O3mT7EBGUqjkpX_ATdpedX
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Relative+survival+of+patients+with+supratentorial+low-grade+gliomas&rft.jtitle=Neuro-oncology+%28Charlottesville%2C+Va.%29&rft.au=Smoll%2C+Nicolas+R&rft.au=Gautschi%2C+Oliver+P&rft.au=Schatlo%2C+Bawarjan&rft.au=Schaller%2C+Karl&rft.date=2012-08-01&rft.eissn=1523-5866&rft.volume=14&rft.issue=8&rft.spage=1062&rft_id=info:doi/10.1093%2Fneuonc%2Fnos144&rft_id=info%3Apmid%2F22773277&rft.externalDocID=22773277
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1522-8517&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1522-8517&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1522-8517&client=summon